Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 3218360)

Published in Protein Sci on August 18, 2011

Authors

Helen M Saunders1, Dimitri Gilis, Marianne Rooman, Yves Dehouck, Amy L Robertson, Stephen P Bottomley

Author Affiliations

1: Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.

Articles citing this

Toward understanding Machado-Joseph disease. Prog Neurobiol (2011) 1.42

Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence. J Mol Biol (2012) 1.37

Trinucleotide repeats: a structural perspective. Front Neurol (2013) 0.89

Aggregation of polyQ proteins is increased upon yeast aging and affected by Sir2 and Hsf1: novel quantitative biochemical and microscopic assays. PLoS One (2012) 0.87

Amyloid-like fibril formation by polyQ proteins: a critical balance between the polyQ length and the constraints imposed by the host protein. PLoS One (2012) 0.84

Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion. Mol Cell Proteomics (2015) 0.81

Protein-protein interactions as a strategy towards protein-specific drug design: the example of ataxin-1. PLoS One (2013) 0.79

Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation. Trends Neurosci (2014) 0.78

Investigation of the Josephin Domain protein-protein interaction by molecular dynamics. PLoS One (2014) 0.77

Josephin Domain Structural Conformations Explored by Metadynamics in Essential Coordinates. PLoS Comput Biol (2016) 0.76

Conformational behavior and aggregation of ataxin-3 in SDS. PLoS One (2013) 0.75

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch. Front Neurosci (2017) 0.75

The Ginkgo biloba Extract EGb 761 Modulates Proteasome Activity and Polyglutamine Protein Aggregation. Evid Based Complement Alternat Med (2014) 0.75

The Protein Structure Context of PolyQ Regions. PLoS One (2017) 0.75

Thermodynamic and kinetic stability of the Josephin Domain closed arrangement: evidences from replica exchange molecular dynamics. Biol Direct (2017) 0.75

Conformational stability of the RNP domain controls fibril formation of PABPN1. Protein Sci (2015) 0.75

Articles cited by this

Selection of representative protein data sets. Protein Sci (1992) 15.62

Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77

The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J Biol Chem (2006) 1.66

The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc Natl Acad Sci U S A (2005) 1.62

PoPMuSiC, an algorithm for predicting protein mutant stability changes: application to prion proteins. Protein Eng (2000) 1.48

Automatic classification and analysis of alpha alpha-turn motifs in proteins. J Mol Biol (1996) 1.41

Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J Mol Biol (2004) 1.41

An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils. Proc Natl Acad Sci U S A (2001) 1.38

Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent beta barrel protein. J Biol Chem (2006) 1.37

Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. J Mol Biol (2005) 1.36

Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J Mol Biol (2007) 1.29

Enhancing the stability and solubility of TEV protease using in silico design. Protein Sci (2007) 1.17

Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem Biophys Res Commun (2004) 1.14

Functional interactions as a survival strategy against abnormal aggregation. FASEB J (2010) 1.13

Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins. Protein Eng Des Sel (2009) 1.12

Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc Natl Acad Sci U S A (2010) 1.11

Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease. J Biol Chem (2004) 1.07

PoPMuSiC, rationally designing point mutations in protein structures. Bioinformatics (2002) 1.06

Towards the treatment of polyglutamine diseases: the modulatory role of protein context. Curr Med Chem (2010) 1.05

Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain. J Neurosci (2004) 1.04

Expansion of amino acid homo-sequences in proteins: insights into the role of amino acid homo-polymers and of the protein context in aggregation. Cell Mol Life Sci (2006) 0.97

Purification of polyglutamine proteins. Methods Enzymol (2006) 0.94

The AXH domain adopts alternative folds the solution structure of HBP1 AXH. Structure (2005) 0.93

The structural impact of a polyglutamine tract is location-dependent. Biophys J (2008) 0.93

PolyQ: a database describing the sequence and domain context of polyglutamine repeats in proteins. Nucleic Acids Res (2010) 0.91

In vitro and in silico design of alpha1-antitrypsin mutants with different conformational stabilities. J Mol Biol (2003) 0.86

Articles by these authors

A common fold mediates vertebrate defense and bacterial attack. Science (2007) 3.43

Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0. Bioinformatics (2009) 2.03

PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality. BMC Bioinformatics (2011) 1.76

Functional insights from the distribution and role of homopeptide repeat-containing proteins. Genome Res (2005) 1.70

The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J Biol Chem (2006) 1.66

The 1.5 A crystal structure of a prokaryote serpin: controlling conformational change in a heated environment. Structure (2003) 1.61

Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J (2005) 1.51

A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production. BMC Biotechnol (2006) 1.48

Molecular gymnastics: serpin structure, folding and misfolding. Curr Opin Struct Biol (2006) 1.47

Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J Exp Med (2004) 1.43

Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor. Immunity (2009) 1.40

MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem (2009) 1.34

Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems. J Biol Chem (2010) 1.32

Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein. J Mol Biol (2007) 1.29

The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J Biol Chem (2005) 1.21

BeAtMuSiC: Prediction of changes in protein-protein binding affinity on mutations. Nucleic Acids Res (2013) 1.21

The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J Biol Chem (2005) 1.20

Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions. Proteins (2013) 1.20

Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein. Biochemistry (2008) 1.18

Inhibitory activity of a heterochromatin-associated serpin (MENT) against papain-like cysteine proteinases affects chromatin structure and blocks cell proliferation. J Biol Chem (2002) 1.17

Enhancing the stability and solubility of TEV protease using in silico design. Protein Sci (2007) 1.17

Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3. Biochem Biophys Res Commun (2004) 1.14

Serpins flex their muscle: II. Structural insights into target peptidase recognition, polymerization, and transport functions. J Biol Chem (2010) 1.14

Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins. Protein Eng Des Sel (2009) 1.12

Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc Natl Acad Sci U S A (2010) 1.11

The subtilisin-like protease AprV2 is required for virulence and uses a novel disulphide-tethered exosite to bind substrates. PLoS Pathog (2010) 1.10

Kinetic instability of the serpin Z alpha1-antitrypsin promotes aggregation. J Mol Biol (2009) 1.10

Specificity and phenetic relationships of iron- and manganese-containing superoxide dismutases on the basis of structure and sequence comparisons. J Biol Chem (2003) 1.09

Protein expression and refolding--a practical guide to getting the most out of inclusion bodies. Biotechnol Annu Rev (2004) 1.08

Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease. J Biol Chem (2004) 1.07

Acid Denaturation of alpha1-antitrypsin: characterization of a novel mechanism of serpin polymerization. J Mol Biol (2002) 1.06

Different conformational changes within the F-helix occur during serpin folding, polymerization, and proteinase inhibition. Biochemistry (2004) 1.06

Antithrombin: in control of coagulation. Int J Biochem Cell Biol (2004) 1.03

The matrix refolded. Nat Methods (2005) 1.01

Human embryonic stem cell models of Huntington disease. Reprod Biomed Online (2009) 0.99

REFOLD: an analytical database of protein refolding methods. Protein Expr Purif (2005) 0.99

Evidence that interaction between conserved residues in transmembrane helices 2, 3, and 7 are crucial for human VPAC1 receptor activation. Mol Pharmacol (2010) 0.99

Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. J Mol Biol (2004) 0.98

Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide. Biophys J (2007) 0.98

The first peptides: the evolutionary transition between prebiotic amino acids and early proteins. J Theor Biol (2009) 0.98

The N terminus of the serpin, tengpin, functions to trap the metastable native state. EMBO Rep (2007) 0.97

A conserved cysteine residue is involved in disulfide bond formation between plant plasma membrane aquaporin monomers. Biochem J (2012) 0.96

Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases. Biochemistry (2002) 0.96

Sequence-structure signals of 3D domain swapping in proteins. J Mol Biol (2003) 0.96

Purification of polyglutamine proteins. Methods Enzymol (2006) 0.94

The structure of the bacterial oxidoreductase enzyme DsbA in complex with a peptide reveals a basis for substrate specificity in the catalytic cycle of DsbA enzymes. J Biol Chem (2009) 0.94

Probing the role of the F-helix in serpin stability through a single tryptophan substitution. Biochemistry (2002) 0.94

X-ray crystal structure of MENT: evidence for functional loop-sheet polymers in chromatin condensation. EMBO J (2006) 0.94

Probing the energetic and structural role of amino acid/nucleobase cation-pi interactions in protein-ligand complexes. J Biol Chem (2002) 0.94

Physical characterization of serpin conformations. Methods (2004) 0.93

Crystal structure of a UDP-glucose-specific glycosyltransferase from a Mycobacterium species. J Biol Chem (2008) 0.93

The structural impact of a polyglutamine tract is location-dependent. Biophys J (2008) 0.93

A protein family under 'stress' - serpin stability, folding and misfolding. Front Biosci (2005) 0.93

DNA accelerates the inhibition of human cathepsin V by serpins. J Biol Chem (2007) 0.92

Production of recombinant serpins in Escherichia coli. Methods (2004) 0.92

Expression, purification and characterization of recombinant Z alpha(1)-antitrypsin--the most common cause of alpha(1)-antitrypsin deficiency. Protein Expr Purif (2009) 0.91

Serpin polymerization and its role in disease--the molecular basis of alpha1-antitrypsin deficiency. IUBMB Life (2009) 0.91

PolyQ: a database describing the sequence and domain context of polyglutamine repeats in proteins. Nucleic Acids Res (2010) 0.91

The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance. J Immunol (2004) 0.90

Promiscuous beta-strand interactions and the conformational diseases. Curr Med Chem (2004) 0.90

PFD: a database for the investigation of protein folding kinetics and stability. Nucleic Acids Res (2005) 0.90

Structure-based mutant stability predictions on proteins of unknown structure. J Biotechnol (2012) 0.90

Structural change in β-sheet A of Z α(1)-antitrypsin is responsible for accelerated polymerization and disease. J Mol Biol (2011) 0.90

Stair motifs at protein-DNA interfaces: nonadditivity of H-bond, stacking, and cation-pi interactions. J Am Chem Soc (2004) 0.89

The REFOLD database: a tool for the optimization of protein expression and refolding. Nucleic Acids Res (2006) 0.89

Protein stability: a single recorded mutation aids in predicting the effects of other mutations in the same amino acid site. Bioinformatics (2011) 0.89

The high resolution crystal structure of a native thermostable serpin reveals the complex mechanism underpinning the stressed to relaxed transition. J Biol Chem (2004) 0.88

Development of novel statistical potentials describing cation-pi interactions in proteins and comparison with semiempirical and quantum chemistry approaches. J Chem Inf Model (2006) 0.88

Thermostability of salt bridges versus hydrophobic interactions in proteins probed by statistical potentials. J Chem Inf Model (2007) 0.88

A structural basis for loop C-sheet polymerization in serpins. J Mol Biol (2008) 0.87

In vitro and in silico design of alpha1-antitrypsin mutants with different conformational stabilities. J Mol Biol (2003) 0.86

Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection. J Immunol (2005) 0.86

Aeropin from the extremophile Pyrobaculum aerophilum bypasses the serpin misfolding trap. J Biol Chem (2007) 0.86

How do proteins avoid becoming too stable? Biophysical studies into metastable proteins. Eur Biophys J (2003) 0.86

Free-energy calculations of protein-ligand cation-pi and amino-pi interactions: from vacuum to proteinlike environments. J Am Chem Soc (2003) 0.86

SODa: an Mn/Fe superoxide dismutase prediction and design server. BMC Bioinformatics (2008) 0.86

Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment. Biophys J (2012) 0.85

Thermo- and mesostabilizing protein interactions identified by temperature-dependent statistical potentials. Biophys J (2010) 0.85

Structural and biochemical characterization of the oxidoreductase NmDsbA3 from Neisseria meningitidis. J Biol Chem (2008) 0.85